22 research outputs found
Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 Cells
INTRODUCTION: Although natural killer (NK) are major cells used to treat cancer patients,
recent clinical trials showed that NK92 cells can be also used for the same purpose due to
their high anti-tumor activity. Here, we examined whether these cells might be inflammatory
due to the release of interleukin-1β (IL-1β), and whether the anti-inflammatory molecules
dimethyl fumarate (DMF), or monomethyl fumarate (MMF) impair this activity.
METHODS: NK92 cells were examined for the synthesis and release of IL-1β utilizing RT-PCR
and ELISA assay, respectively. The expression of hydroxy-carboxylic acid receptors (HCA)1,
HCA2 and HCA3 was detected by immunoblotting, flow cytometry, immunofluorescence and
RT-PCR assays. The activation of caspase-1 and Gasdermin D (GSDMD) was evaluated by
immunoblot assay. Pyroptosis was demonstrated by immunofluorescence imaging. Expression
of DNA methyltransferases (DNMTs) mRNA was determined by whole transcriptome and
immunoblot analyses.
RESULTS: LPS-induced the release of IL-1β from NK92 cells, whereas DMF or MMF inhibited
this induction. The effect of these drugs was due to inhibiting the conversion of procaspase-1
into active caspase-1. NK92 cells highly expressed GSDMD, a pyroptotic-mediated molecule.
However, LPS induced the distribution of GSDMD into the cell membranes, corroborated with
the presence of pyroptotic bodies, an activity that was inhibited by DMF or MMF. These
molecule also inhibited the generation of GSDMD through DNMT-mediated hypermethylation
of the promoter region of GSDMD gene. These results were supported by increased expression
of DNMTs mRNA as determined by whole transcriptome analysis.
DISCUSSION: Our results are the first to show that NK92 cells utilize GSDMD pathway to
release IL-1β. Further, DMF and MMF which were previously shown to enhance NK cell
cytotoxicity, also inhibit the inflammatory effects of these cells, making them most suitable
for treating cancer patients
Shear strength of reinforced concrete dapped-end beams using mechanism analysis.
yesA mechanism analysis based on the upper-bound theorem of concrete plasticity is developed to predict the critical
failure plane and corresponding shear capacity of reinforced concrete dapped-end beams. Failure modes observed in
physical tests of reinforced concrete dapped-end beams are idealised as an assemblage of two moving blocks separated
by a failure surface of displacement discontinuity. The developed mechanism analysis rationally represents the effect of
different parameters on failure modes; as a result, the predicted shear capacity is in good agreement with test results.
On the other hand, empirical equations specified in the Precast/Prestressed Concrete Institute design method and strutand-tie
model based on ACI 318-05 highly underestimate test results. The shear capacity of dapped-end beams predicted
by the mechanism analysis and strut-and-tie model decreases with the increase of shear span-to-full beam depth ratio
when failure occurs along diagonal cracks originating at the bottom corner of the full-depth beam, although the shear
span-to-full beam depth ratio is ignored in the Precast/Prestressed Concrete Institute design method
Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue
Besides the respiratory system, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection was shown to affect other essential organs such as the kidneys. Early kidney involvement during the course of infection was associated with worse outcomes, which could be attributed to the direct SARS-CoV-2 infection of kidney cells. In this study, the effect of commonly used medications on the expression of SARS-CoV-2 receptor, angiotensin-converting enzyme (ACE)2, and TMPRSS2 protein in kidney tissues was evaluated. This was done by in silico analyses of publicly available transcriptomic databases of kidney tissues of rats treated with multiple doses of commonly used medications. Of 59 tested medications, 56% modified ACE2 expression, whereas 24% modified TMPRSS2 expression. ACE2 was increased with only a few of the tested medication groups, namely the renin-angiotensin inhibitors, such as enalapril, antibacterial agents, such as nitrofurantoin, and the proton pump inhibitor, omeprazole. The majority of the other medications decreased ACE2 expression to variable degrees with allopurinol and cisplatin causing the most noticeable downregulation. The expression level of TMPRSS2 was increased with a number of medications, such as diclofenac, furosemide, and dexamethasone, whereas other medications, such as allopurinol, suppressed the expression of this gene. The prolonged exposure to combinations of these medications could regulate the expression of ACE2 and TMPRSS2 in a way that may affect kidney susceptibility to SARS-CoV-2 infection. Data presented here suggest that we should be vigilant about the potential effects of commonly used medications on kidney tissue expression of ACE2 and TMPRSS2
Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling
Since its emergence as a pandemic in March 2020, coronavirus disease (COVID-19) outcome has been explored via several predictive models, using specific clinical or biochemical parameters. In the current study, we developed an integrative non-linear predictive model of COVID-19 outcome, using clinical, biochemical, immunological, and radiological data of patients with different disease severities. Initially, the immunological signature of the disease was investigated through transcriptomics analysis of nasopharyngeal swab samples of patients with different COVID-19 severity versus control subjects (exploratory cohort, n=61), identifying significant differential expression of several cytokines. Accordingly, 24 cytokines were validated using a multiplex assay in the serum of COVID-19 patients and control subjects (validation cohort, n=77). Predictors of severity were Interleukin (IL)-10, Programmed Death-Ligand-1 (PDL-1), Tumor necrosis factors-α, absolute neutrophil count, C-reactive protein, lactate dehydrogenase, blood urea nitrogen, and ferritin; with high predictive efficacy (AUC=0.93 and 0.98 using ROC analysis of the predictive capacity of cytokines and biochemical markers, respectively). Increased IL-6 and granzyme B were found to predict liver injury in COVID-19 patients, whereas interferon-gamma (IFN-γ), IL-1 receptor-a (IL-1Ra) and PD-L1 were predictors of remarkable radiological findings. The model revealed consistent elevation of IL-15 and IL-10 in severe cases. Combining basic biochemical and radiological investigations with a limited number of curated cytokines will likely attain accurate predictive value in COVID-19. The model-derived cytokines highlight critical pathways in the pathophysiology of the COVID-19 with insight towards potential therapeutic targets. Our modeling methodology can be implemented using new datasets to identify key players and predict outcomes in new variants of COVID-19
Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East
International travel played a significant role in the early global spread of SARS-CoV-2. Understanding transmission patterns from different regions of the world will further inform global dynamics of the pandemic. Using data from Dubai in the United Arab Emirates (UAE), a major international travel hub in the Middle East, we establish SARS-CoV-2 full genome sequences from the index and early COVID-19 patients in the UAE. The genome sequences are analysed in the context of virus introductions, chain of transmissions, and possible links to earlier strains from other regions of the world. Phylogenetic analysis showed multiple spatiotemporal introductions of SARS-CoV-2 into the UAE from Asia, Europe, and the Middle East during the early phase of the pandemic. We also provide evidence for early community-based transmission and catalogue new mutations in SARS-CoV-2 strains in the UAE. Our findings contribute to the understanding of the global transmission network of SARS-CoV-2